Skip to main content
All Posts By

Kristian Andersen

Translational science pilot study awards fuel innovation Translational InstituteNewsTraining

Translational science pilot study awards fuel innovation

Two early-stage scientists in the lab have been awarded grants for translational science research projects through the Scripps Research Translational Institute’s Pilot Study Award Program. The program supports scientists who strive to conduct transformative research with the potential to accelerate medical breakthroughs. Translational science is the process of turning observations in the laboratory into interventions, including new medicines, diagnostics or…
July 16, 2024
Preliminary Report on H5N1 in Cattle H5N1 treeNarrativeNews

Preliminary Report on H5N1 in Cattle

During the winter of 2020-2021, a new genotype of highly-pathogenic (HP) H5N1 avian influenza A virus emerged in Europe, comprising a reassortant between the epizootic HP clade 2.3.4.4b H5N8 and local low pathogenicity wildfowl strains. This new genotype caused record levels of infections in farmed poultry throughout Europe and quickly traveled, via waterfowl flyways, into North America, Africa and East…
May 3, 2024
SEARCH Paper out in Cell Cell abstractPublications

SEARCH Paper out in Cell

Elucidating human contact networks could help predict and prevent the transmission of SARS-CoV-2 and future pandemic threats. A new study from Scripps Research scientists and collaborators points to which public health protocols worked to mitigate the spread of COVID-19—and which ones didn’t. In the study, published online in Cell on December 14, 2023, the Scripps Research-led team of scientists investigated the efficacy…
December 14, 2023
Discrimination in science Andersen Lab 2022Other

Discrimination in science

Recently one of our colleagues made comments at a scientific meeting about male scientists being the subject of discrimination. In a follow up interview, he suggested that discussions about diversity, equity, and inclusion in science were not welcome or appropriate topics for scientific meetings. While we respect each individual’s right to their own views, we do not believe that either of these…
December 4, 2023
Gates support for wastewater surveillance Wastewater surveillance projectPress Releases

Gates support for wastewater surveillance

Wastewater surveillance is a cost-effective, convenient tool for tracking harmful pathogens circulating through the population, but technology and infrastructure hurdles have limited its widespread use. The Bill & Melinda Gates Foundation has awarded Scripps Research a $1.5 million grant to overcome these barriers, expand wastewater surveillance tracking, and help mitigate infectious disease threats around the globe. The two-year award, which…
August 30, 2023
International collaboration strengthens global disease surveillance News

International collaboration strengthens global disease surveillance

Increasingly researchers have used wastewater surveillance as an effective tool to find out what viruses and which strains of viruses—for example, SARS-CoV-2 variants—are circulating within a community. Providing real-time insights into which diseases might be on the rise helps public health officials to detect and contain outbreaks before they become global pandemics. In late Spring 2023, Scripps Research postdoctoral associates…
August 11, 2023
Congressional Testimony Wald PlaneNews

Congressional Testimony

This is a collection of material relevant to the July 11, 2023 hearing with the Select Subcommittee on the Coronavirus Pandemic. The hearing, titled "Investigating the Proximal Origin of a Cover Up". The hearing itself is a clear example of the politicization of scientific questions and targeting of scientists that have published peer-reviewed papers that go against a preferred political…
July 13, 2023
CViSB Center renewed with $12.8 million grant Press Releases

CViSB Center renewed with $12.8 million grant

Scientists at Scripps Research have received a significant grant to study the evolution and outcomes of human infections with SARS-CoV-2, Lassa virus and Ebola virus. The team will receive roughly $2.5 million each year for a maximum of five years, bringing the total potential award to $12.8 million. The funds—a grant renewal from the the National Institutes of Health’s (NIH)…
April 13, 2023
Close Menu